For: | Polvani S, Tarocchi M, Tempesti S, Galli A. Nuclear receptors and pathogenesis of pancreatic cancer. World J Gastroenterol 2014; 20(34): 12062-12081 [PMID: 25232244 DOI: 10.3748/wjg.v20.i34.12062] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i34/12062.htm |
Number | Citing Articles |
1 |
Simone Polvani, Sara Pepe, Sara Tempesti, Mirko Tarocchi, Giada Marroncini, Lapo Bencini, Elisabetta Ceni, Tommaso Mello, Lucia Picariello, Irene Simeone, Cecilia Grappone, Gabriele Dragoni, Lorenzo Antonuzzo, Elisa Giommoni, Stefano Milani, Andrea Galli. Isoforms of the orphan nuclear receptor COUP‑TFII differentially modulate pancreatic cancer progression. International Journal of Oncology 2022; 60(5) doi: 10.3892/ijo.2022.5345
|
2 |
Xiaoyong Zhi, X. Edward Zhou, Karsten Melcher, H. Eric Xu. Structures and regulation of non-X orphan nuclear receptors: A retinoid hypothesis. The Journal of Steroid Biochemistry and Molecular Biology 2016; 157: 27 doi: 10.1016/j.jsbmb.2015.06.012
|
3 |
Stephen L. Abrams, Shaw M. Akula, Alberto M. Martelli, Lucio Cocco, Stefano Ratti, Massimo Libra, Saverio Candido, Giuseppe Montalto, Melchiorre Cervello, Agnieszka Gizak, Dariusz Rakus, Linda S. Steelman, James A. McCubrey. Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53. Advances in Biological Regulation 2021; 79: 100780 doi: 10.1016/j.jbior.2020.100780
|
4 |
Imlimaong Aier, Rahul Semwal, Anju Sharma, Pritish Kumar Varadwaj. In silico identification of therapeutic compounds against microRNA targets in drug-resistant pancreatic ductal adenocarcinoma. Journal of Biomolecular Structure and Dynamics 2021; 39(13): 4893 doi: 10.1080/07391102.2020.1782262
|
5 |
Kohei Yamakawa, Michiyo Koyanagi-Aoi, Akihito Machinaga, Nobuyuki Kakiuchi, Tomonori Hirano, Yuzo Kodama, Takashi Aoi. Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02928-4
|
6 |
Mallika Bhattacharya, Michelle Starz-Gaiano. Steroid hormone signaling synchronizes cell migration machinery, adhesion and polarity to direct collective movement. Journal of Cell Science 2024; 137(5) doi: 10.1242/jcs.261164
|
7 |
Kexin Li, Baofeng Xu, Guangying Xu, Rui Liu. CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. Tumor Biology 2016; 37(1): 419 doi: 10.1007/s13277-015-3819-y
|
8 |
Cong Wang, Hui Cai, Qiuyin Cai, Jie Wu, Rachael Stolzenberg‐Solomon, Xingyi Guo, Claire Zhu, Yu‐Tang Gao, Jordan Berlin, Fei Ye, Wei Zheng, Veronica Wendy Setiawan, Xiao‐Ou Shu. Circulating microRNAs in association with pancreatic cancer risk within 5 years. International Journal of Cancer 2024; 155(3): 519 doi: 10.1002/ijc.34956
|
9 |
Danila Cuomo, Immacolata Porreca, Gilda Cobellis, Roberta Tarallo, Giovanni Nassa, Geppino Falco, Antonio Nardone, Francesca Rizzo, Massimo Mallardo, Concetta Ambrosino. Carcinogenic risk and Bisphenol A exposure: A focus on molecular aspects in endoderm derived glands. Molecular and Cellular Endocrinology 2017; 457: 20 doi: 10.1016/j.mce.2017.01.027
|
10 |
Sahat Matondang, Benedicta Mutiara Suwita, Taufik Budianto, Ening Krisnuhoni. Atypical CT and MR imaging of insulinoma: A case report. Journal of Clinical and Translational Endocrinology: Case Reports 2021; 19: 100075 doi: 10.1016/j.jecr.2020.100075
|
11 |
Stephen L. Abrams, Kvin Lertpiriyapong, Li V. Yang, Alberto M. Martelli, Lucio Cocco, Stefano Ratti, Marco Falasca, Ramiro M. Murata, Pedro L. Rosalen, Paolo Lombardi, Massimo Libra, Saverio Candido, Giuseppe Montalto, Melchiorre Cervello, Linda S. Steelman, James A. McCubrey. Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals. Advances in Biological Regulation 2018; 69: 16 doi: 10.1016/j.jbior.2018.06.002
|
12 |
Agustina Ramírez‐Moreno, Martha Angélica Quintanar Escorza, Rubén García Garza, Keita Hady, Adrian Meléndez Valenzuela, Jolanta E. Marszalek, Ibrahim Sharara‐Núñez, Dealmy Delgadillo‐Guzmán. All‐trans retinoic acid improves pancreatic cell proliferation on induced type 1 diabetic rats. Fundamental & Clinical Pharmacology 2020; 34(3): 345 doi: 10.1111/fcp.12523
|
13 |
Tomonari KOBARAI, Takahiro OGAWA, Kei FUJII, Gen NARITOMI, Shinji KOHNO, Toru EGUCHI. A Case of Pancreatic Metastasis from Breast Cancer Treated with Pancreaticoduodenectomy. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2016; 77(10): 2538 doi: 10.3919/jjsa.77.2538
|
14 |
Malek Zihlif, Tareq Hameduh, Nailya Bulatova, Hana Hammad. Alteration in the expression of the chemotherapy resistance‑related genes in response to chronic and acute hypoxia in pancreatic cancer. Biomedical Reports 2023; 19(6) doi: 10.3892/br.2023.1670
|
15 |
Zhiping Fu, Xing Liang, Ligang Shi, Liang Tang, Danlei Chen, Anan Liu, Chenghao Shao. SYT8 promotes pancreatic cancer progression via the TNNI2/ERRα/SIRT1 signaling pathway. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00779-4
|
16 |
Jimmy El Hokayem, Celeste Amadei, Jean-Pierre Obeid, Zafar Nawaz. Ubiquitination of nuclear receptors. Clinical Science 2017; 131(10): 917 doi: 10.1042/CS20160708
|
17 |
|
18 |
Simone Polvani, Sara Pepe, Stefano Milani, Andrea Galli. COUP-TFII in Health and Disease. Cells 2019; 9(1): 101 doi: 10.3390/cells9010101
|
19 |
William J. Hubbard, Kirby I. Bland, Irshad H. Chaudry. The ERRor of Our Ways. Shock 2015; 44(1): 3 doi: 10.1097/SHK.0000000000000364
|
20 |
Tao Wang, Jian-Qiong Xiong. The Orphan Nuclear Receptor TLX/NR2E1 in Neural Stem Cells and Diseases. Neuroscience Bulletin 2016; 32(1): 108 doi: 10.1007/s12264-015-0004-7
|
21 |
Simone Polvani, Mirko Tarocchi, Sara Tempesti, Lapo Bencini, Andrea Galli. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer. World Journal of Gastroenterology 2016; 22(8): 2441-2459 doi: 10.3748/wjg.v22.i8.2441
|
22 |
J. Christopher Corton, Jeffrey M. Peters, James E. Klaunig. The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions. Archives of Toxicology 2018; 92(1): 83 doi: 10.1007/s00204-017-2094-7
|
23 |
Eduardo Mere Del Aguila, Xiao-Han Tang, Lorraine J. Gudas. Pancreatic Ductal Adenocarcinoma: New Insights into the Actions of Vitamin A. Oncology Research and Treatment 2022; 45(5): 291 doi: 10.1159/000522425
|
24 |
Michael R. Ludwig, Kyoko Kojima, Gregory J. Bowersock, Dongquan Chen, Nirag C. Jhala, Donald J. Buchsbaum, William E. Grizzle, Christopher A. Klug, James A. Mobley. Surveying the serologic proteome in a tissue‐specific kras(G12D) knockin mouse model of pancreatic cancer. PROTEOMICS 2016; 16(3): 516 doi: 10.1002/pmic.201500133
|
25 |
Jun Zhou, Xiaoliang Hui, Ying Mao, Liya Fan. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis. Bioscience Reports 2019; 39(8) doi: 10.1042/BSR20190625
|
26 |
Li Ji, Chen Gong, Liangyu Ge, Linping Song, Fenfen Chen, Chunjing Jin, Hongyan Zhu, Guoxiong Zhou. Orphan nuclear receptor Nurr1 as a potential novel marker for progression in human pancreatic ductal adenocarcinoma. Experimental and Therapeutic Medicine 2017; 13(2): 551 doi: 10.3892/etm.2016.3968
|
27 |
Morteza Zarrabi, Elaheh Afzal, Marzieh Ebrahimi. Manipulation of Hematopoietic Stem Cell Fate by Small Molecule Compounds. Stem Cells and Development 2018; 27(17): 1175 doi: 10.1089/scd.2018.0091
|
28 |
Nikitha Vobugari, Kai Sun. Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies. 2023; doi: 10.5772/intechopen.110216
|
29 |
|
30 |
Bibiana Ortega-Domínguez, Marlene Herrera-Ramírez, Angeles C. Tecalco-Cruz. RECEPTORES NUCLEARES: DEL NÚCLEO AL CITOPLASMA. TIP 2015; 18(2): 131 doi: 10.1016/j.recqb.2015.09.005
|